Title	Management of Acute Coronary Syndromes [electronic resource] / edited by Christopher P. Cannon
Imprint	Totowa, NJ : Humana Press : Imprint: Humana Press, 2003
Edition	Second Edition
Connect to	http://dx.doi.org/10.1007/978-1-59259-351-4
Descript	XV, 783 p. online resource

In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). These world-renowned experts review: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-anti- thrombotic regimens. They also discuss the latest developments in interventional cardiology (early invasive approach in higher risk ACS patients and the promise of drug-coated stents), and analyze cost-effectiveness in clinical trials to choose appropriate therapies. Current trial data are included, along with practical recommendations on how these data may be applied in daily practice. Comprehensive and authoritative, Management of Acute Coronary Syndromes, Second Edition, succinctly presents cardiologists, internists, primary care and emergency physicians, fellows, and residents with an up-to-the-minute review of the many recent advances that have transformed our understanding of the pathophysiology, diagnosis, and management of patients with acute coronary syndromes

I Pathophysiology -- 1 The Spectrum of Myocardial Ischemia: The Paradigm of Acute Coronary Syndromes -- 2 Linking Biochemistry, Vascular Biology, and Clinical Events in Acute Coronary Syndromes -- 3 Triggers of Acute Coronary Syndromes -- 4 Insights into the Pathophysiology of Acute Ischemia Syndromes Using the TIMI Flow Grade, TIMI Frame Count, and TIMI Myocardial Perfusion Grade -- II Diagnosis -- 5 Emergency Department Presentations of Acute Cardiac Ischemia -- 6 Early Identification and Treatment of Patients with Acute Coronary Syndromes -- 7 Serum Markers for Diagnosis and Risk Stratification in Acute Coronary Syndromes -- 8 Technologies to Diagnose Acute Ischemia -- III ST-Segment Elevation Myocardial Infarction -- 9 Thrombolytic Therapy -- 10 Primary Angioplasty -- 11 Expanding the Access to Percutaneous Coronary Intervention for Patients Admitted to Community Hospitals -- 12 Antiplatelet and Anticoagulant Therapy -- 13 ?-Adrenergic Blockers, Calcium Channel Blockers, and Nitrates -- 14 Angiotensin Converting Enzyme Inhibitors After and During Acute Coronary Syndromes, and, in Particular, Myocardial Infarction -- 15 Risk Stratification: Exercise Testing, Imaging, and Cardiac Catheterization -- IV Non-ST-Segment Elevation Myocardial Infarction -- 16 Anticoagulant Therapies -- 17 Antiplatelet Therapy -- 18 Thrombolytics and Invasive vs Conservative Strategies in Unstable Angina -- 19 Current Device Strategies in the Management of Acute Coronary Syndromes -- V Special Aspects of Acute Coronary Syndromes -- 20 Women and Acute Coronary Syndromes -- 21 The Modern Strategy for Cardiogenic Shock -- 22 Myocardial Infarction in the Younger Patient -- 23 Cholesterol Lowering -- 24 โ{128}{156}Secondary Preventionโ{128}{157} of Myocardial Infarction -- 25 Cost and Cost-Effectiveness in Acute Coronary Syndromes -- 26 Smoking Cessation -- 27 Critical Pathways for Acute Coronary Syndromes